Bellus Health (BLU) has a debt-to-equity ratio of 0.04, below the Healthcare sector average of 0.3.
Get informed when a big investor buys or sells
+ Follow0.04
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
The latest debt-to-equity ratio for BLU is 0.04. That is below the Healthcare sector average of 0.3. Investors often review this figure alongside Bellus Health's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, BLU currently prints 0.04 for debt-to-equity ratio, while the sector average sits near 0.3. That is roughly 86.6% below the sector mean. Large gaps often invite a closer look at Bellus Health's growth, margins, and balance sheet.
A debt-to-equity ratio of 0.04 for Bellus Health is not 'good' or 'bad' on its own. Compare it with the peer average (0.3) and with BLU's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting BLU's debt-to-equity ratio (0.04), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Bellus Health's debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.